GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.76 $2.31 Wednesday, 17th Apr 2024 CTMX stock ended at $1.76. This is 5.38% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 5.68% from a day low at $1.76 to a day high of $1.86.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
2023-12-28 $1.56 $1.60 $1.50 $1.55 771 881
2023-12-27 $1.50 $1.55 $1.48 $1.55 460 703
2023-12-26 $1.46 $1.50 $1.45 $1.48 350 158
2023-12-22 $1.40 $1.46 $1.40 $1.44 160 871
2023-12-21 $1.32 $1.43 $1.32 $1.41 315 318
2023-12-20 $1.38 $1.44 $1.33 $1.34 264 841
2023-12-19 $1.41 $1.44 $1.40 $1.41 182 313
2023-12-18 $1.41 $1.44 $1.39 $1.41 158 163
2023-12-15 $1.46 $1.50 $1.40 $1.41 202 484
2023-12-14 $1.45 $1.49 $1.43 $1.47 147 483
2023-12-13 $1.40 $1.46 $1.39 $1.44 255 779
2023-12-12 $1.41 $1.45 $1.37 $1.41 96 193
2023-12-11 $1.44 $1.45 $1.33 $1.39 344 917
2023-12-08 $1.45 $1.49 $1.42 $1.47 279 273
2023-12-07 $1.48 $1.48 $1.42 $1.46 249 150
2023-12-06 $1.45 $1.50 $1.43 $1.46 347 614
2023-12-05 $1.44 $1.44 $1.41 $1.41 97 095
2023-12-04 $1.37 $1.46 $1.37 $1.44 317 991
2023-12-01 $1.37 $1.43 $1.36 $1.41 204 112
2023-11-30 $1.40 $1.43 $1.37 $1.39 240 117
2023-11-29 $1.35 $1.41 $1.33 $1.33 255 802
2023-11-28 $1.35 $1.39 $1.32 $1.35 96 519
2023-11-27 $1.34 $1.39 $1.33 $1.33 256 297
2023-11-24 $1.35 $1.38 $1.29 $1.36 130 604
2023-11-22 $1.31 $1.31 $1.22 $1.29 98 217
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT